The levels of TRAIL, IP-10, and Nab inhibition rates to omicron type SARS-CoV-2 BA.1, BA.2, and BA.5 subvariants in maternal blood from participants receiving 2, 3, and 4 doses of COVID-19 vaccine. The gene discussed is CXCL10; the disease is COVID-19.